CIPO trademark

OMNIPODPROMISE

RegisteredCIPOWord markClass 9Class 10Class 35

"OMNIPODPROMISE" is a word mark owned by Insulet Corporation, filed at the CIPO on November 23, 2021. It is registered and covers classes 9, 10 and 35.

Official CIPO record
OMNIPODPROMISE
Word mark as filed with the CIPO
Status
Registered
Since July 18, 2025
Filed
November 23, 2021
Registered
July 18, 2025
Expires
July 18, 2035
Application no.
2149161
Registration no.
TMA1332487
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
3 classes
Ownership

Who owns OMNIPODPROMISE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services OMNIPODPROMISE is filed for, grouped by Nice class.

  • Downloadable software in the nature of applications for mobile phone and smart phones providing information and personal medical data relating to diabetes management, insulin, sugar levels and related diabetes data; Downloadable and recorded software and computer hardware for use in insulin monitoring and tracking blood glucose levels; downloadable and recorded software and computer hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded software and computer hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management

  • Medical devices, namely, implantable drug delivery pumps and ports, sold empty, smart delivery devices, sold empty, in the nature of implantable drug delivery pumps and ports for communicating with smart devices for data processing, wearable subcutaneous drug delivery devices, sold empty in the nature of injectors, on-body injectors, all sold empty; diabetes management devices, in the nature of blood glucose meters, blood sugar level monitors, blood sugar reading instruments, infusion pumps, infusion pump controllers and component parts and fittings thereof

  • Providing a consumer trade-in and upgrade program for used drug delivery and diabetes management medical devices when newer models of the devices are available

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Registered
  2. Registration Pending
  3. Advertised; Vol.72 Issue 3679
  4. Approval Notice Sent; APPROVED BY PROGRAM EX200M1
  5. Approved; APPROVED BY PROGRAM EX200M1
  6. Examiner's First Report
  7. Search Recorded
  8. Pre-Assessment Letter Sent; Goods or Services Not Acceptable
  9. Formalized
  10. Created

1 earlier step on the official record.

FAQ

About OMNIPODPROMISE

Who owns the trademark "OMNIPODPROMISE"?

The CIPO trademark "OMNIPODPROMISE" (application 2149161) is owned by Insulet Corporation.

What is the status of "OMNIPODPROMISE"?

Its status at the CIPO is: registered.

When was "OMNIPODPROMISE" registered?

It was registered on July 18, 2025 and is due to expire on July 18, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull OMNIPODPROMISE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019deb42-8c6c-74ba-83a3-d752a43a845f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb42-8c6c-74ba-83a3-d752a43a845f",
  "object": "trademark",
  "mark_text": "OMNIPODPROMISE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "2149161",
  "filing_date": "2021-11-23",
  "nice_classes": [
    9,
    10,
    35
  ],
  "owners": [
    {
      "name": "Insulet Corporation",
      "entity_id": "ent_019eb703-f31b-77f7-9e7b-5b872cd9cb48"
    }
  ]
}